History
  • No items yet
midpage
770 F. Supp. 2d 1153
W.D. Wash.
2011
Read the full case

Background

  • Plaintiff Mirina Corporation alleges trademark infringement, trade name infringement, false designation of origin, unfair competition, and WCPA violation against Marina Biotech.
  • Marina Biotech changed its name from MDRNA, Inc. to Marina Biotech in July 2010; Mirina filed a Mirina mark application five days later.
  • Both parties operate in RNA-based therapeutics; Mirina focuses on microRNA drugs, while Marina Biotech works on RNA interference products.
  • Plaintiff argues confusion between Mirina and Marina Biotech due to phonetic similarity of marks; Defendant argues lack of close proximity and identity in services.
  • Court analyzes likelihood of confusion under the Sleekcraft eight-factor test and Winter framework for preliminaryinjunctions, and ultimately denies Mirina's motion.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Likelihood of confusion standard applies Mirina argues confusion is likely due to phonetic similarity and shared channels. Marina Biotech contends confusion is not sufficiently probable given weak proximity and other factors. Likelihood of confusion present but not strong enough
Irreparable harm presumption post-Winter Irreparable harm presumed from infringement risk and loss of goodwill. Winter requires showing likely irreparable harm; no proven reputational harm or non-monetary injury. No irreparable harm shown
Balance of hardships and public interest Injunction necessary to prevent investor confusion and protect Mirina's mark. Defendant would bear rebranding costs and other harms; Mirina lacks demonstrated goodwill. Hardships do not tip in Mirina's favor; public interest not sufficient
Likelihood of success on merits Sleekcraft factors favor Mirina due to phonetic similarity and channels. Evidence does not show strong proximity, strength, or actual confusion; defenses prevail. Serious questions exist, but not sufficient for success on merits at this stage

Key Cases Cited

  • Winter v. NRDC, 555 U.S. 7 (United States Supreme Court 2008) (redefines preliminary injunction standards)
  • AMF, Inc. v. Sleekcraft Boats, 599 F.2d 341 (9th Cir. 1979) (eight-factor test for likelihood of confusion)
  • Freecycle Network, Inc. v. Oey, 505 F.3d 898 (9th Cir. 2007) (likelihood of confusion framework)
  • Brookfield Communications, Inc. v. West Coast Entertainment Corp., 174 F.3d 1036 (9th Cir. 1999) (initial interest confusion concept)
  • Alliance for the Wild Rockies v. Cottrell, 632 F.3d 1127 (9th Cir. 2011) (serious questions version remains viable after Winter)
  • Morningside Group Ltd. v. Morningside Capital Group, 182 F.3d 133 (2d Cir. 1999) (investor sophistication and potential confusion)
  • Internet Specialties West, Inc. v. Milon-DiGiorgio Enters., Inc., 559 F.3d 985 (9th Cir. 2009) (public interest in avoiding confusion)
Read the full case

Case Details

Case Name: Mirina Corp. v. Marina Biotech
Court Name: District Court, W.D. Washington
Date Published: Mar 7, 2011
Citations: 770 F. Supp. 2d 1153; 2011 U.S. Dist. LEXIS 28117; 2011 WL 909355; Case C10-1322RAJ
Docket Number: Case C10-1322RAJ
Court Abbreviation: W.D. Wash.
Log In